A citation-based method for searching scientific literature

Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
Times Cited: 143



Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu, David E Goldgar, Mary Beth Terry, Matti A Rookus, Douglas F Easton, Antonis C Antoniou, Lesley McGuffog, D Gareth Evans, Daniel Barrowdale, Debra Frost, Julian Adlard, Kai-Ren Ong, Louise Izatt, Marc Tischkowitz, Ros Eeles, Rosemarie Davidson, Shirley Hodgson, Steve Ellis, Catherine Nogues, Christine Lasset, Dominique Stoppa-Lyonnet, Jean-Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J Hooning, Lizet E van der Kolk, Carolien M Kets, Muriel A Adank, Esther M John, Wendy K Chung, Irene L Andrulis, Melissa Southey, Mary B Daly, Saundra S Buys, Ana Osorio, Christoph Engel, Karin Kast, Rita K Schmutzler, Trinidad Caldes, Anna Jakubowska, Jacques Simard, Michael L Friedlander, Sue-Anne McLachlan, Eva Machackova, Lenka Foretova, Yen Y Tan, Christian F Singer, Edith Olah, Anne-Marie Gerdes, Brita Arver, Håkan Olsson. JAMA 2017
Times Cited: 1027




List of shared articles



Times cited

Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.
Claire Saule, Solveig Menu-Hespel, Matthieu Carton, Caroline Malhaire, Pascal Cherel, Fabien Reyal, Marine Le Mentec, Eugénie Guillot, Anne Donnadieu, Nasrine Callet,[...]. Eur J Hum Genet 2022
0


Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer.
Susana I S Patuleia, Sophie C Hagenaars, Cathy B Moelans, Margreet G E M Ausems, Carla H van Gils, Rob A E M Tollenaar, Paul J van Diest, Wilma E Mesker, Elsken van der Wall. Cancer Epidemiol Biomarkers Prev 2021
3


Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper.
Nicole E Cousens, Jane Tiller, Bettina Meiser, Kristine Barlow-Stewart, Simone Rowley, Yi-An Ko, Sakshi Mahale, Ian G Campbell, Rajneesh Kaur, Agnes Bankier,[...]. BMJ Open 2021
0

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.
Marion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, Lucas Mizrahy, Sandrine Akouete, Helena Huguet, Frédéric Thomas, David Geneviève, Patrice Taourel, Marc Ychou,[...]. Genes (Basel) 2021
0

Inter- and intra-observer agreement on evaluating the presence of residual glandular tissue with magnetic resonance tomography following prophylactic mastectomy.
Märta A Skoglund, Magnus N Andersson, Annika Björkgren, Ernst Tolocka, Malin Sund, Rebecca Wiberg. Acta Radiol 2021
0

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
9



High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Ulrich Bick, Christoph Engel, Barbara Krug, Walter Heindel, Eva M Fallenberg, Kerstin Rhiem, David Maintz, Michael Golatta, Dorothee Speiser, Dorothea Rjosk-Dendorfer,[...]. Breast Cancer Res Treat 2019
42

Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
Yael Laitman, Dana Madorsky Feldman, Miri Sklair-Levy, Ady Yosepovich, Iris Barshack-Nakar, Malka Brodsky, Osnat Halshtok, Anat Shalmon, Michael Gotlieb, Eitan Friedman. Clin Breast Cancer 2018
2